This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially IntroductIonSturge-Weber Syndrome (SWS) is a birth set, neuromuscular syndrome. The disease appears as vascular skin lesions, general complaints, and ophthalmic symptoms. They mainly include glaucoma, choroidal hemangioma of the fundus, vascular lesions of the eyelids, and anterior eye segment. Diagnosis and treatment can be difficult. This paper aims to present the course and treatment of SWS for ophthalmic patients in long-term observation. case presentatIon case 1A 16-year-old female was referred to the Glaucoma Outpatient Clinic (GOC) due to elevated intraocular pressure in both eyes in applanation tonometry (IOP), up to 26 mm Hg for the right eye and up to 29 for the left eye despite timolol administered 2 times per day. The patient presented port-wine stains (PWS) on the face and neck, noticed after birth. Due to clinical suspicion of SWS,

The aim of the study is to analyse the postoperative results of continuous wave, transscleral cyclophotocoagulations (CW-TSCPC) in 6 months follow-up for patients with refractory glaucoma. Material and methods: We retrospectively reviewed 58 records of patients who underwent the transscleral cyclophotocoagulation because of refractory glaucoma at the Department of Ophthalmology, Poznan University of Medical Sciences, Poland, between 2016 and 2022. All patients underwent ophthalmological examination at baseline and during follow-up visits including best-corrected visual acuity, intraocular pressure measurement (IOP), slit-lamp examination, visual field and optical coherence tomography examination of the retinal nerve fiber layer (OCT RNFL). Follow-up time was 6 months. Results: We analyzed a group of 58 patients (28 women and 30 men, average age of 62). Majority of patients (41 eyes, 70.69%) had secondary open angle glaucoma. There were no serious complications of the CW-TSCPC procedure. We achieved IOP normalization (IOP below 22 mmHg) in 81.03% of eyes in 1 month follow-up, in 81.08% after 2 months, and in 72.41% after 6 months. Mean IOP reduction was 53.47%, 47.71%, and 47.65% from baseline at 1, 2, and 6 months, respectively. The number of medications taken by patients was lowered of 74.14%, 70.27% and 68.97% after 1, 2 and 6 months respectively. 17 eyes (29.31%) required additional surgical interventions within 6 months. Conclusions: CW-TSCPC is an effective and safe procedure. It allows lowering of IOP and reduction of drugs number administrated by patients with various types of glaucoma during 6 months follow-up. The procedure is technically easy and with well-controlled postoperative complications.